Zagazig University & Egyptian International Pharmaceutical Industries Company, EIPICO | Egypt

Ahmed Sobhy Abdelrahim Abdallah Darwish is a highly accomplished analytical chemist with extensive expertise in analytical methodologies and chemical research. His academic journey demonstrates a consistent commitment to scientific rigor, progressing from a strong foundation in chemistry and physics to advanced studies in analytical chemistry. He has completed a diploma in analytical chemistry with distinction, a pre-master qualification with outstanding performance, and a master’s degree in analytical chemistry. Currently pursuing a Ph.D. in the same field, his research is centered on the development, optimization, and validation of analytical techniques for pharmaceutical and industrial applications. His work emphasizes precision, reliability, and innovation in chemical analysis, including method development for complex matrices, quality control protocols, and instrumental analysis techniques. His contributions aim to enhance the accuracy and efficiency of laboratory workflows, ensuring robust and reproducible results in pharmaceutical and chemical research. Additionally, he demonstrates proficiency in data interpretation, statistical analysis, and experimental design, contributing to high-quality scientific outcomes. His ongoing research reflects a commitment to advancing analytical chemistry through both theoretical insights and practical applications, positioning him as a significant contributor to the field and a strong candidate for recognition in research excellence.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Ma, J. K., Darwish, A. S., Al Ali, A., Abdelazim, A. M., Darwish, W. S., Li, X., & Huang, X. C. (2025). An ecologically sound HPLC determination of LEVOMENOL in topical therapies using a certified reference material with green properties. Results in Chemistry, 13, 102338.

Alenezi, S. S., Gouda, A. A., El Sheikh, R., Badahdah, N. A., Alzuhiri, M. E., & others. (2025). Environmental sustainability profiles assessment of HPLC stability indicating method for quantitation of piracetam and vincamine in pharmaceutical medications. Talanta Open, 11, 100407.

Darwish, A. S., Zaki, M. S. A., Salih, A. G. K. A., Ellatif, M. A., Patel, A. A., Mallick, A. K., & others. (2025). A simple eco‐friendly stability‐indicating HPLC method for determination of NETILMICIN in bulk and ophthalmic solution. Biomedical Chromatography, 39(8), e70152.

Gouda, A. A., Elsheikh, R., Eldien, A. S., & Darwish, A. S. (2025). Development and validation of stability indicating RP-HPLC method for simultaneous determination of simvastatin and fenofibrate in bulk and dosage form. Bulletin of Faculty of Science, Zagazig University, 2025(3), 134–146.

Huang, X. C., Darwish, A. S., Darwish, W. S., Chen, R. M., & Ma, J. K. (2025). Green rapid HPLC method for testing retinol and tocopherol in ophthalmic gels. Talanta Open, 100538.

Darwish, A. S., Gouda, A. A., & Eldien, A. S. (2025). Simple validated approach to quantify valsartan and sacubitril in medications using liquid chromatography. Bulletin of Faculty of Science, Zagazig University, 2025(3), 216–229.

Darwish, W. S. D., Zaki, M. S. A., Salih, A. G. K. A., & others. (2025). Developing a sensitive, ecological, and economic HPLC method for the concurrent quantification of KOLCHICINE and KHELLIN, used in bulk and sachet pharmaceuticals. Microchemical Journal, 114716.

Ma, J. K., Chen, X. Y., Zhang, N., Darwish, A. S., Gouda, A. A., El Sheikh, R., & others. (2025). A straightforward HPLC approach to testing butylated hydroxytoluene, an antioxidant, in pure and topical anti-burn gels; evaluation of greenness, blueness, and whiteness grades. Talanta Open, 100565.

Huang, X. C., Darwish, A. S., Darwish, W. S., Zaki, M. S. A., Lin, Y. T., Liang, N. L., & Ma, J. K. (2025). Ecologically conscious profiles assessments for economic, and concurrent HPLC detection of chlordiazepoxide and clidinium bromide in bulk and tablets solid dosage form. Results in Chemistry, 1, 102739.

Meenakshi | Signal Transduction Networks | Research Excellence Award

Published on 02/12/202502/12/2025 by Cell Biologist

Assoc. Prof. Dr. Meenakshi | Signal Transduction Networks | Research Excellence Award

Chandigarh University | India

Dr. Meenakshi Munjal is an active researcher in the field of wireless communication, contributing extensively to advancements in emerging communication technologies. Over the past several years, she has maintained a strong research trajectory, completing one funded research project and producing a substantial body of scholarly work. Her research output includes more than 30 Scopus-indexed publications and a total citation count of 100, reflecting the growing impact of her contributions within the scientific community. She has authored one book with an ISBN and has two patents published or under process, demonstrating her commitment to innovation and applied research in communication systems. In addition to her publications, she has published eight peer-reviewed journal articles across SCI and Scopus-indexed platforms, strengthening the scientific understanding of wireless networks, signal processing, and communication technologies. Her work aligns with contemporary challenges in wireless systems, contributing to enhanced network performance, reliability, and efficiency. She also holds three professional memberships, supporting collaborative engagement within the research ecosystem. Overall, her research contributions highlight a sustained focus on innovation, scholarly excellence, and the advancement of wireless communication technologies

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Munjal, M., & Singh, N. P. (2018). Utility aware network selection in small cell. Wireless Networks, 1–14.

Munjal, M., & Singh, N. P. (2019). Group mobility by cooperative communication for high speed railway. Wireless Networks, 25(7), 3857–3866.

Gupta, S. (2014). A review and comprehensive comparison of image denoising techniques. Proceedings of the International Conference on Computing for Sustainable Global Development, 1–6.

Munjal, M., & Singh, N. P. (2019). QoS and cost-aware protocol selection for next generation wireless network. Journal of Network and Systems Management, 27(2), 327–350.

Munjal, M., & Singh, N. P. (2017). Improved network selection for multimedia applications. Transactions on Emerging Telecommunications Technologies, 28(5), e3121.

Munjal, M., & Singh, N. P. (2016). A comparative study of cooperative and non-cooperative game theory in network selection. Computational Techniques in Information and Communication Technologies Conference Proceedings, 1–5.

Meenakshi, G., & Gupta, S. (2014). Advanced level cyclic gray codes with application. International Journal of Electronics Communication and Computer Technology, 1–6.

Munjal, M., & Singh, N. P. (2020). Low cost communication for high speed railway. Wireless Personal Communications, 111(1), 163–178.

Munjal, M. (2024). A comprehensive review of wireless body area network in medical applications. AIP Conference Proceedings, 3100(1), 040013.

Munjal, M., & Dev, S. (2021). Utility based handoff decision for Internet of Everything (IoE). Photonics & Electromagnetics Research Symposium (PIERS) Proceedings, 1396–1405.

Singh, I., & Munjal, M. (2025). Intelligent network selection mechanisms in the Internet of Everything system. IEEE Access.

Munjal, M., Kaistha, K., Gupta, P., Sardana, L., Verma, R., & Verma, S. (2024). Handoff management using RSS in a heterogeneous system. AIP Conference Proceedings, 3072(1), 030003.

Willa Hsueh | Immunometabolism | Best Researcher Award

Published on 09/10/202509/10/2025 by Cell Biologist

Prof. Willa Hsueh | Immunometabolism | Best Researcher Award

The Ohio State University | United States

Dr. Willa Hsueh is a leading researcher in endocrinology, diabetes, and metabolism, with a career spanning several decades of pioneering contributions to hormone regulation and metabolic disease. Her early research provided key insights into renin biochemistry and aldosterone metabolism, particularly focusing on inactive “big renin” forms and their activation mechanisms in normal and pathological conditions such as diabetic nephropathy. Dr. Hsueh’s investigations have significantly advanced the understanding of the renin-angiotensin-aldosterone system (RAAS) and its role in blood pressure regulation, sodium balance, and endocrine disorders. Her studies explored adrenal physiology, steroid metabolism, and hormonal responses to physiological and pharmacological stimuli, laying the groundwork for later research on cardiovascular and metabolic dysfunctions in diabetes. Through her interdisciplinary approach combining endocrinology, nephrology, and metabolism, she has elucidated biochemical pathways linking hormonal imbalances to metabolic diseases. Dr. Hsueh continues to lead impactful research in diabetes and metabolic regulation, contributing to translational advancements that bridge molecular mechanisms with clinical applications for improved patient outcomes in endocrine and metabolic disorders.

Profiles: Scopus | Orcid

Featured Publications:

Hsueh, W. A., Boonjaren, S., Stein, J., Baehler, H. R., Osgood, R. W., Cohen, S., Yashon, D., & Ferris, T. (1974). Effect of plasma sodium concentration on diluting segment sodium reabsorption. Kidney International, 5(1), 1–11.

Johnson, K. R., Hsueh, W. A., Glusman, S. M., & Arnett, F. C. (1976). Fibrous myopathy: A rheumatic complication of drug abuse. Arthritis & Rheumatism, 19(5), 923–926.

Hsueh, W. A., & Hsu, T. H. (1978). Thyrotoxicosis in a patient with secondary hypothyroidism. Southern Medical Journal, 71(9), 1174–1177.

Hsueh, W. A., Luetscher, J. A., Carlson, E., & Grislis, G. (1978). Big renin in plasma of healthy subjects on high-sodium intake. The Lancet, 1(8077), 1281–1284.

Hsueh, W. A., Hsu, T. H., & Federman, D. D. (1978). Endocrine features of Klinefelter’s syndrome. Medicine, 57(5), 447–461.

Hsueh, W. A., Luetscher, J. A., Carlson, E., Grislis, G., Elbaum, D., & Chavarri, M. (1978). A comparison of cold and acid activation of big renin and of inactive renin in normal plasma. Journal of Clinical Endocrinology and Metabolism, 47(4), 792–799.

Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Published on 01/08/202501/08/2025 by Cell Biologist

Assist. Prof. Dr. Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Alejandro Rojas | Austral University of Chile | Germany

Dr. Alejandro Alfredo Rojas Fernández is a distinguished Chilean molecular biotechnologist and neuroscientist, currently serving as CEO of Berking Theranostics UG in Hamburg, Germany, and Assistant Professor at the Universidad Austral de Chile. With over two decades of research spanning neurodegeneration, immunology, and viral pathogenesis, Dr. Rojas-Fernández has emerged as a leading expert in molecular diagnostics and theranostics. His innovative work has significantly impacted global health, notably through his contributions to SARS-CoV-2 research and senolytic therapies. A dual academic and entrepreneur, he bridges fundamental science and clinical application, actively publishing in top-tier journals such as Nature Aging, Molecular Psychiatry, and Journal of Cell Biology. Fluent in interdisciplinary collaboration, his efforts have been internationally recognized with multiple honors. With a passion for translational science, Dr. Rojas-Fernández continues to inspire the next generation of biomedical innovators through mentorship and leadership in biotechnology and neuroscience.

Publication Profile:

Orcid

Education:

Dr. Alejandro Rojas-Fernández earned his PhD in Biology from the University of Konstanz, Germany (2006–2010), where his research focused on the regulation of Hdm2/HdmX-mediated ubiquitination and neddylation—mechanisms central to protein stability and cancer biology. Prior to his doctorate, he completed his engineering degree in Molecular Biotechnology (2004–2005) and his B.Sc. in Molecular Biotechnology Engineering (2000–2004) at the Faculty of Sciences, University of Chile—one of Latin America’s leading research institutions. His multidisciplinary education integrates molecular biology, neurobiology, immunology, and translational medicine, equipping him with the foundational and advanced tools to tackle complex biomedical challenges. Dr. Rojas-Fernández’s academic training has been marked by academic excellence and international mobility, enabling him to collaborate and lead research projects across Europe and Latin America.

Experience:

Dr. Rojas-Fernández brings over 20 years of experience in translational biomedical research, academia, and biotech innovation. As CEO of Berking Theranostics UG, he spearheads the development of personalized diagnostic platforms and therapeutics, with a focus on neurodegenerative and inflammatory diseases. In his role as Assistant Professor at Universidad Austral de Chile (20% appointment), he leads the Medical Biotechnology Laboratory within the Centre for Interdisciplinary Studies on the Nervous System (CISNe), contributing to scientific training and cutting-edge research. He previously trained and collaborated at institutions such as the University of Dundee, University of Queensland, and University of Constance, advancing molecular mechanisms of SUMOylation, proteostasis, inflammasome biology, and viral-host interactions. His interdisciplinary expertise allows him to translate complex cellular insights into tangible clinical applications, and his leadership has resulted in high-impact publications, product pipelines, and strategic biotech partnerships in Europe and Latin America.

Awards and Honors:

Dr. Rojas-Fernández has received multiple prestigious honors recognizing his innovative biomedical research. In February 2025, he was named “Innovator of the Month” by Hamburg Invest for groundbreaking biotech contributions in Germany. He was awarded the Medal of the City of Valdivia for his vital role in controlling the SARS-CoV-2 pandemic, one of the highest local honors in Chile. Additionally, he received the 2nd of October Medal for Science and Innovation, recognizing his scientific leadership in Chile’s Los Ríos region. These accolades underscore his impact on global public health, neurodegenerative research, and biotechnology entrepreneurship. His consistent recognition reflects a career dedicated to translational excellence, fostering international collaboration, and advancing science for the benefit of society. His scientific achievements continue to inspire innovation and interdisciplinary approaches within the global scientific community.

Research Focus:

Dr. Alejandro Rojas-Fernández’s research centers on cellular stress responses, ubiquitin/SUMO signaling, neurodegeneration, and host-pathogen interactions. A core focus is the molecular crosstalk between autophagy, protein quality control, and inflammasome activation in brain and immune cells. He has made significant advances in understanding the effects of SARS-CoV-2 on microglia, mechanisms of senescence in aging brains, and nanobody-based viral neutralization. His studies also explore the intersection of endoplasmic reticulum stress and neurodegenerative pathways, using high-content screening and proteomics to uncover therapeutic targets. He actively translates molecular insights into diagnostics and theranostic tools, positioning him at the forefront of personalized medicine. As CEO of a biotech startup, he is developing platforms that integrate biomarker discovery with AI for neuroinflammation profiling. His research bridges fundamental biology and clinical applications, promoting innovative therapies for Alzheimer’s, Parkinson’s, cancer, and viral infections.

Publications Top Notes:

Negative Modulation of Macroautophagy by Stabilized HERPUD1… – Front Cell Dev Biol, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia… – Mol Psychiatry, 2022
The p97/VCP segregase is essential for arsenic-induced degradation of PML… – J Cell Biol, 2023
Lack of Parkinsonian Pathology after Proteasome Inhibitor Injection… – Front Aging Neurosci, 2021
NSPA modulates postsynaptic NMDAR stability… – BMC Biol, 2020
Role of PSMD14 in Golgi-to-ER transport and APP processing – Cells, 2020
WDR90 in NLRC4 inflammasome and Salmonella resistance – Dev Comp Immunol, 2019
Proteomic identification of APC interaction partners – Mol Cancer Res, 2019
DHX15 regulates CMTR1-dependent gene expression – Life Sci Alliance, 2018
Membrane ruffling by polarized stim1 and orai1 – Sci Reports, 2017

Conclusion:

Dr. Alejandro Alfredo Rojas Fernández stands out as a pioneering researcher who consistently delivers scientifically rigorous, socially impactful, and clinically relevant work. His career spans critical sectors—basic research, applied biotechnology, and public health—making him a model example of the translational scientist. With accolades from both European and Latin American institutions and a track record of high-impact publications, Dr. Rojas exemplifies what it means to be a globally relevant and community-driven scientist. His work during the COVID-19 pandemic, innovations in molecular neuroscience, and leadership in therapeutic biotechnology underscore his immense value to the global research community. In conclusion, he is not only a suitable but a highly deserving candidate for the Best Researcher Award.

Yanhe Han | Microbial Cell Biology | Best Researcher Award

Published on 22/07/202522/07/2025 by Cell Biologist

Prof. Yanhe Han | Microbial Cell Biology | Best Researcher Award

Prof. Yanhe Han, Beijing Institute of Petrochemical Technology, China

Dr. Han Yanhe is an accomplished environmental engineer and Associate Professor at Beijing Institute of Petro-Chemical Technology, China. With over 20 years of academic and research experience, Dr. Han has focused on cutting-edge wastewater treatment technologies, such as electrochemical catalytic oxidation and micro-electrolysis. A Ph.D. graduate from Dalian University of Technology, his work bridges practical environmental challenges and sustainable engineering solutions. Internationally recognized, Dr. Han completed a research fellowship at Griffith University, Australia, expanding his global academic footprint. His research has led to over 15 high-impact publications, addressing pollutant degradation, water quality detection, and novel electrode materials. In addition to research, he teaches core subjects like water pollution control and environmental quality assessment, nurturing the next generation of environmental scientists. Dr. Han’s integrated approach to technology development and practical applications places him at the forefront of environmental research in China and globally.

Publication Profile:

Scopus

Strengths for the Award:

Innovative Research Excellence
Dr. Han is a leader in environmental engineering, particularly in the development of electrochemical and micro-electrolysis technologies for advanced wastewater treatment. His innovations target real-world environmental challenges, such as industrial wastewater degradation, phosphorus removal, and simultaneous pollution treatment and energy recovery.
Prolific Academic Output
With over 15 peer-reviewed international publications, many in top-tier journals such as Journal of Hazardous Materials, Separation and Purification Technology, and Chemical Engineering Journal, Dr. Han has established a strong global academic presence.
Interdisciplinary & Application-Oriented Work
His research integrates environmental science, electrochemistry, and materials engineering — demonstrating a rare interdisciplinary depth and high potential for real-world application, especially in energy-efficient and sustainable water treatment systems.
Global Experience & Recognition
His research fellowship at Griffith University, Australia, reflects international collaboration and visibility, reinforcing his status as a globally competent researcher.
Teaching and Mentorship
Dr. Han is committed to education, offering over a decade of university-level teaching experience in core environmental engineering subjects, while mentoring new researchers in practical and theoretical aspects of the field.

Areas for Improvement:

International Research Collaboration
While his research is impactful, greater involvement in international joint projects, EU or UN-led sustainability frameworks could amplify his global research influence.
Industry-Academic Partnerships
Collaborations with industrial partners for pilot-scale or commercial deployment of his technologies could enhance technology transfer and societal impact.
Research Visibility and Citations
Actively promoting his work through keynote talks, media, or open-access platforms may further boost citations and recognition.

Education:

Dr. Han Yanhe earned his Ph.D. and Master’s degrees in Environmental Engineering from the School of Environmental and Biological Science & Technology at Dalian University of Technology (2001–2006). His research focused on the electrochemically enhanced adsorption of organic pollutants using activated carbon fibers, reflecting a strong foundation in both theoretical and applied chemistry. Before that, he obtained his Bachelor’s degree in Environmental Engineering from Xi’an University of Engineering Science & Technology (1997–2001), where he gained fundamental skills in chemical processes and pollution control. His education reflects a consistent trajectory in environmental sciences, building both his research capabilities and practical engineering knowledge. These academic qualifications have shaped his expertise in advanced wastewater treatment technologies and environmental monitoring systems, forming the core of his research and professional contributions in later years.

Experience:

Dr. Han Yanhe is currently an Associate Professor at Beijing Institute of Petro-Chemical Technology (since 2011), where he leads research in electrochemical wastewater treatment and teaches environmental engineering. He was previously a Research Fellow at Griffith University, Australia (2009–2011), contributing to international research in water pollution control. From 2006 to 2009, Dr. Han served as Senior Lecturer and later Associate Professor at Liaoning Normal University. Across these roles, he has developed innovative technologies for water treatment, including internal circulation micro-electrolysis reactors and pollutant degradation methods. His leadership in both academic and research domains is evident through a strong publication record, supervision of student research, and cross-disciplinary project involvement. His international and domestic experience underscores a deep commitment to solving environmental challenges through sustainable technologies.

Research Focus:

Dr. Han Yanhe’s research centers on advanced wastewater treatment and environmental monitoring. His primary areas include electrochemical catalytic oxidation, iron-carbon micro-electrolysis, and autotrophic denitrification technologies aimed at treating industrial pollutants. He also works on real-time water quality monitoring, developing rapid detection equipment for COD, BOD, and toxicity. A notable innovation is the development of synchronous wastewater treatment and hydrogen production technologies, integrating environmental sustainability with clean energy generation. Additionally, he has contributed to the pretreatment of refractory industrial wastewater and the use of computational fluid dynamics for reactor optimization. Dr. Han’s multidisciplinary work combines chemical engineering, environmental science, and materials science, enabling the design of efficient, scalable, and eco-friendly solutions for water treatment. His focus on practical application, supported by a solid theoretical foundation, distinguishes his work in the environmental engineering field.

Publications Top Notes:

Electrooxidation degradation of bisphenol A: pathways and toxicity analysis – Separation and Purification Technology, 2024
Iron-carbon micro-electrolysis reactor for aniline wastewater: mechanism and pathways – Chinese Journal of Chemical Engineering, 2023
Fe/C-MgCO₃ micro-electrolysis fillers for phosphorus removal – Environmental Science and Pollution Research, 2022
High-efficiency PbO₂ anode via Ce-GO doping: electrochemical study – Journal pending, 2022
Integrated COD and BOD determination technique – Polish Journal of Environmental Studies, 2021
Sulfate removal via internal circulation iron-carbon micro-electrolysis – Separation and Purification Technology, 2021
Electro-coagulation of hydrolyzed polyacrylamide: optimization study – Desalination and Water Treatment, 2020
Electrochemical oxidation of HPAM at Ti/SnO₂-Sb₂O₃/β-PbO₂ Anode – Int. J. Electrochemical Science, 2020
Hydrodynamic simulation in micro-electrolysis reactors – Chemical Engineering Journal, 2020
Micro-electrolysis biological fluidized bed for coking wastewater – Journal of Water Process Engineering, 2020

Conclusion:

Dr. Han Yanhe stands out as a highly qualified candidate for the Best Researcher Award. His innovative contributions in environmental engineering, particularly in wastewater treatment and electrochemical systems, are of high scientific value and societal relevance. Backed by strong academic output, international exposure, and sustained commitment to teaching, Dr. Han exemplifies the excellence this award seeks to recognize.

Zhaowei Feng | Stem Cell Research | Best Researcher Award

Published on 02/07/202502/07/2025 by Cell Biologist

Dr. Zhaowei Feng | Stem Cell Research | Best Researcher Award

Dr. Zhaowei Feng, The Second Affiliated Hospital of Xuzhou Medical University, China

Zhaowei Feng is a dedicated biomedical researcher specializing in neurobiology and pharmacology, currently serving as an Assistant Researcher at The Second Affiliated Hospital of Xuzhou Medical University. With a solid academic foundation and a passion for neuroscience, Feng has made significant contributions to understanding mechanisms of neuroprotection and demyelination. His research spans neurodegenerative disease models such as multiple sclerosis and neonatal hypoxia-ischemia, utilizing molecular and cellular biology tools. Known for his collaborative nature and scientific rigor, Feng has co-authored multiple peer-reviewed articles in prestigious journals and has played pivotal roles in various national and municipal-level research projects. He is particularly recognized for co-first authorship in several studies, reflecting leadership in experimental design and data analysis. His growing influence in the field is further supported by ongoing funded projects and a research trajectory aimed at translational outcomes. Feng is committed to continuing impactful research that bridges bench science with clinical applications.

Publication Profile:

Scopus

✅ Strengths for the Award:

Strong Research Focus in Neurobiology 🧠
Zhaowei Feng has a consistent and impactful research portfolio in neurobiology, particularly in myelination, ischemia-reperfusion injury, and glutamate signaling. His work is highly relevant in addressing diseases like multiple sclerosis and neonatal hypoxia-ischemia encephalopathy.
Publications in High-Impact Journals 📚
He has co-authored several peer-reviewed journal articles in reputable journals such as Phytomedicine, Pharmacology, Oncology Reports, and Frontiers. His contributions as co-first author in multiple papers reflect significant involvement in study design and experimentation.
Independent Researcher Role 🧪
He currently serves as a Principal Investigator for a municipal-level research project funded by the Xuzhou Health Commission, demonstrating trust in his leadership and research direction.
Multidisciplinary Expertise 🔬
His research integrates pharmacology, molecular biology, and neuroscience, covering diverse mechanisms like PPARγ signaling, SUMOylation, and ferroptosis, which enhances translational potential.
Rapid Academic Growth 🚀
Transitioning quickly from a Master’s student (2019–2022) to Assistant Researcher and PI (since 2022) shows a fast-tracked academic trajectory.

⚠️ Areas for Improvement:

Need for More First-Author and Corresponding-Author Papers ✍️
While co-first authorship is commendable, a stronger emphasis on sole first or corresponding authorship in future publications would establish more scientific independence.
Limited Recognition at National Level 🏅
Most current funding and achievements are at the municipal level. Applying for national or international grants (e.g., NSFC, NIH) would elevate his research profile.
Postdoctoral Training or Collaboration Abroad 🌍
Gaining international experience or collaborating with global research centers could broaden perspectives and techniques, increasing citation impact and networking.
More Diversified Research Outputs 📊
Exploring patents, clinical trials, or translational research outcomes could further demonstrate innovation and application potential.

🎓 Education:

Zhaowei Feng began his academic journey in the biological sciences at Xuzhou Medical University, where he earned his Bachelor’s degree between 2014 and 2018. He further pursued a Master’s degree in Neurobiology at the same institution from September 2019 to July 2022. His graduate studies were marked by an intensive focus on neurodegenerative mechanisms, including demyelination and neuroinflammation, with particular attention to cuprizone-induced and ischemia-reperfusion mouse models. His research also explored glutamate transport regulation, the PPARγ pathway, and oligodendrocyte differentiation. His educational foundation not only provided him with technical proficiency in experimental neuroscience but also cultivated a strong understanding of translational biomedical research. Through rigorous coursework, laboratory experience, and thesis writing, Feng developed a robust academic profile that seamlessly transitioned into his research career. His educational journey reflects consistent dedication and a clear trajectory towards clinical and experimental neurobiology.

🧪 Experience:

Since September 2022, Zhaowei Feng has been working as an Assistant Researcher at The Second Affiliated Hospital of Xuzhou Medical University. His role involves leading preclinical studies, managing collaborative projects, and mentoring junior researchers. Feng has also served as Principal Investigator on a municipal-level research grant focusing on blood-brain barrier damage post-transplantation. He actively participates in multiple interdisciplinary studies involving neurodevelopment, myelination, and pharmacological interventions. Prior to his current role, his Master’s research provided hands-on experience with animal models, molecular techniques, and data analysis in neurobiology. Feng has authored or co-authored numerous research papers, some as co-first author, contributing significantly to study design and execution. He is also involved in translational research projects that aim to bridge laboratory findings with clinical therapies. His work ethic, attention to detail, and innovative approach make him a valuable contributor to the field of neurobiological research.

🏅 Awards and Honors:

Zhaowei Feng has been recognized for his scientific contributions through both academic and research-oriented accolades. Notably, he is the recipient of a research grant from the Xuzhou Municipal Health Commission (Project No. XWKYHT20230029), focusing on cerebral ischemia-reperfusion and blood-brain barrier injury. Though early in his professional career, his selection as Principal Investigator on this project signifies trust in his leadership and expertise. Several of his publications in high-impact journals list him as co-first author—an honor that highlights his equal contribution in rigorous experimental work. While he has yet to receive national awards such as from the Natural Science Foundation, his steady academic output and funded research projects mark a strong trajectory. His growing publication record and role in significant studies position him as a rising talent in the biomedical field. Future honors are likely as his research continues to address key questions in neuroscience and pharmacology.

🔬 Research Focus:

Zhaowei Feng’s research centers on neuroprotection, demyelination, and neuroinflammation, with a particular focus on the mechanisms underlying multiple sclerosis, ischemic brain injury, and neonatal encephalopathy. His studies often employ animal models such as cuprizone-induced demyelination and hypoxia-ischemia to explore therapeutic targets. Feng is particularly interested in the regulation of oligodendrocyte differentiation and the role of glutamate transporters, signaling molecules like PPARγ, and pathways involving Wnt/β-catenin and SUMOylation. Additionally, he has investigated compounds such as diosgenin and alpha-asaronol for their neuroprotective and remyelination-promoting effects. His work also extends into cancer biology, with studies on ferroptosis and protein regulation in squamous cell carcinoma. By integrating molecular biology, pharmacology, and neurodevelopmental research, Feng aims to contribute to the discovery of new treatments for central nervous system disorders. His current and future research is geared toward translational medicine that bridges laboratory science with clinical applications.

📚 Publication Top Notes:

🧠 Alpha-Asaronol Alleviates Dysmyelination by Enhancing Glutamate Transport via PPARγ-GLT-1 Signaling in Neonatal Hypoxia-Ischemia (Pharmacology, 2022)
🧬 C1q Inhibits Differentiation of Oligodendrocyte Progenitor Cells via Wnt/β-Catenin Signaling (Biomedicine & Pharmacotherapy, 2023)
🧪 Alpha-Asaronol Promoted OPC Differentiation and Improved Myelination as a PPARγ Activator (Frontiers, 2023)
🧫 Diosgenin Promoted OPC Differentiation by Blocking GLUR2/GAPDH Interaction in Pilocarpine-Induced Epilepsy Rats (Phytomedicine, 2025)
🧬 Netrin-4 Mediates Piezo1 Inactivation and YAP Signaling Alleviation in Cerebral Ischemia-Reperfusion (Oncology Reports)
🔬 SENP1 Inhibits Ferroptosis and Promotes Head and Neck Squamous Cell Carcinoma by Regulating ACSL4 Protein (Molecular Oncology, 2023)
🧪 SUMO1-Mediated Stabilization Enhances Protein Function in Neuroinflammatory Models (Unspecified Journal)
🧠 Signaling Activation in a Cuprizone-Induced Mouse Model of Multiple Sclerosis (Unspecified Journal)

📌 Conclusion:

Zhaowei Feng is a highly promising early-career researcher with a clear scientific focus, a growing publication record, and demonstrated ability to lead independent research. His work addresses critical challenges in neurobiology and pharmacology, making a tangible impact in both experimental and translational medicine. With continued progression—especially toward national-level recognition and senior authorship—he has the potential to become a leader in his field.

Gisela D’ANGELO | Cell Biology and Cancer | Best Researcher Award

Published on 17/06/202517/06/2025 by Cell Biologist

Dr. Gisela D’ANGELO | Cell Biology and Cancer | Best Researcher Award

Dr. Gisela D’ANGELO, CNRS, France

Dr. Gisela D’Angelo is a distinguished cell biologist and Research Director at CNRS, currently based at Institut Curie, Paris. Born in Montevideo, Uruguay (1961), she has built a notable career in molecular biology, specializing in the roles of extracellular vesicles (EVs) in cell communication, development, and disease. With over three decades of international experience and a profound academic foundation from top French institutions, she has contributed significantly to understanding vesicle-mediated signaling pathways. Her work has reshaped knowledge of cellular dynamics in development, virology, and cancer. She is affiliated with the UMR144 Cell Biology and Cancer Department, and her scientific leadership has guided impactful projects and collaborations across Europe. A mentor to several postdoctoral researchers, her prolific publication record and active role in translational research solidify her position as a leader in EV biology.

Publication Profile:

Scopus

Orcid

✅ Strengths for the Award:

World-Class Researcher in Extracellular Vesicles (EVs):
Dr. D’Angelo has made pivotal contributions to understanding the biogenesis and function of extracellular vesicles in both developmental and pathological contexts, such as placental biology, viral infection, and cancer.
Prolific Publication Record:
She has authored and co-authored multiple high-impact journal articles in top-tier journals like PNAS, Nature Methods, Current Biology, and Development. Her publications are often collaborative and interdisciplinary, indicating a strong network in the global scientific community.
Leadership Role and Institutional Prestige:
Holding the title of Research Director (DR2 CNRS) at the Institut Curie—a premier research center in Europe—underscores her leadership and scientific excellence. She also mentors young scientists and leads innovative projects.
Innovative Use of Imaging & Model Systems:
Her work combines advanced microscopy, Drosophila genetics, and molecular biology to explore intercellular communication—offering novel insights with translational potential.
International Profile and Experience:
Originally from Uruguay, educated in Paris, and professionally established in France, Dr. D’Angelo reflects a truly international scientific career.

⚠️ Areas for Improvement:

Teaching and Public Engagement:
While she is involved in a Master-level course, increasing her visibility in teaching, mentoring, and public science outreach could enhance her broader scientific influence.
Expanded Global Collaborations:
Most of her research collaborations are within France or Europe. Developing larger-scale international consortia or initiatives could amplify her global impact.
Science Communication and Media Presence:
Her profile and findings could benefit from more exposure via science communication platforms, conferences, and open-access forums to reach broader audiences.

🎓 Education:

Dr. Gisela D’Angelo’s academic journey began at Université Pierre et Marie Curie (Paris VI), where she earned a BS in Cell Biology and Physiology (1984), followed by a Master’s degree in Reproductive Physiology (1986). She went on to complete her PhD in Molecular Biology and Reproductive Physiology in 1990 at the same university. Her research skills and academic rigor led her to pursue the Habilitation à Diriger des Recherches (HDR) in 2003 at Université de Nice Sophia-Antipolis, qualifying her to supervise doctoral research and lead independent scientific programs. Her education laid a strong interdisciplinary foundation, integrating molecular biology, cell physiology, and developmental biology—skills that she continues to apply in her research on intercellular communication and extracellular vesicles.

💼 Experience:

Dr. D’Angelo began her research career in France, first as a Research Associate at INSERM U615, University of Nice (2000–2005), followed by a role at CNRS UMR 7277/INSERM 1091 (2005–2017). She then joined Institut Curie, Paris, as a Senior Research Scientist (CRCN, CNRS), and was promoted to Research Director in 2024. Her extensive experience spans cellular communication, reproductive biology, and cancer research, with a focus on extracellular vesicles (EVs). She undertook a sabbatical at Institut Curie in 2016, which helped deepen collaborative efforts in vesicle biology. She is recognized for leading multidisciplinary teams, mentoring early-career scientists, and contributing to major breakthroughs in developmental biology, particularly through high-resolution imaging and molecular tools. With over 20 publications in top-tier journals, Dr. D’Angelo’s career reflects innovation, academic rigor, and impactful science.

🔬 Research Focus:

Dr. Gisela D’Angelo’s research revolves around the biogenesis, trafficking, and function of extracellular vesicles (EVs)—small, membrane-bound particles that mediate intercellular communication. Her work elucidates how EVs participate in developmental signaling pathways, immune regulation, placental communication, and disease pathogenesis (e.g., cancer, viral infections). A core part of her focus is understanding how microvilli-derived vesicles contribute to morphogenesis and tissue homeostasis, using advanced imaging and model organisms like Drosophila. She has also explored EV modifications by pathogens such as cytomegalovirus and their effects on fetal development. Her cutting-edge research combines molecular genetics, imaging technologies, and cell biology to dissect the subcellular mechanics of EV trafficking. As a leading figure in this dynamic field, she has significantly advanced understanding of how EVs act as messengers during physiological and pathological processes, making her work highly relevant to regenerative medicine, oncology, and developmental biology.

📚 Publications Top Notes:

🧪 Extracellular vesicles released by keratinocytes regulate melanosome maturation, melanocyte dendricity, and pigment transfer – PNAS, 2024
🤰 Placental extracellular vesicles in maternal-fetal communication during pregnancy – Biochemical Society Transactions, 2022
🦠 Human Cytomegalovirus modifies placental small extracellular vesicle composition to enhance infection of fetal neural cells in vitro – Viruses, 2022
🧬 Microvilli-derived extracellular vesicles carry Hedgehog morphogenic signals for Drosophila wing imaginal disc development – Current Biology, 2022
🔬 The power of imaging to understand extracellular vesicle biology in vivo – Nature Methods, 2021
🧫 Human Cytomegalovirus infection changes the pattern of surface markers of small extracellular vesicles – Frontiers in Cell and Developmental Biology, 2021
🧠 Centrosome amplification mediates small extracellular vesicle secretion via lysosome disruption – Current Biology, 2021
🧭 The GTPase Rab8 differentially controls Hedgehog gradient by regulating its apico-basal distribution – Development, 2021
🐛 Microvilli-derived extracellular vesicles govern morphogenesis in Drosophila wing epithelium – bioRxiv preprint, 2020
🧪 Centrosome amplification mediates EV secretion via lysosome disruption – bioRxiv preprint, 2020
🧩 The cell biology of extracellular vesicles: A jigsaw puzzle with a myriad of pieces – Review/Essay (unlisted journal)

🧾 Conclusion:

Dr. Gisela D’Angelo is highly suitable for the Best Researcher Award. Her exceptional contributions to extracellular vesicle research—combined with leadership, publication quality, and scientific impact—place her among the top scientists in her field. While she could enhance her visibility in teaching and international collaboration, her track record demonstrates consistent excellence, innovation, and commitment to advancing biomedical research. She represents the ideal profile of a senior investigator who bridges fundamental science and translational relevance.

Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Published on 23/05/202523/05/2025 by Cell Biologist

Dr. Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Naoki Harada, Osaka Metropolitan University, Japan

Naoki Harada is an Associate Professor at Osaka Metropolitan University, Japan, with extensive expertise in molecular biology, biochemistry, endocrinology, and nutrition. He earned his Ph.D. in Life Sciences from Osaka Prefecture University in 2007. Over the past two decades, Harada has made significant contributions to understanding the physiological and biochemical mechanisms underpinning metabolic diseases, particularly type 2 diabetes. His research, characterized by high citation impact (H-index of 25), centers on pancreatic β-cell function and metabolic regulation. He has published 77 peer-reviewed articles and holds a patent related to therapeutic interventions. Harada has collaborated with leading scientists like Professors Hiroshi Inui and Ryoichi Yamaji, strengthening his academic footprint in both national and international circles. A member of multiple scientific societies, Harada continues to influence the field through impactful research, industry collaboration, and educational leadership.

Publication Profile:

Orcid

✅ Strengths for the Award:

Consistent Research Output
- 77 peer-reviewed publications in reputable journals (SCI, Scopus).
- Recent high-impact studies published in Journal of Biological Chemistry, Scientific Reports, and FASEB BioAdvances.
- Active research profile with an H-index of 25 and over 1,785 citations.
Innovative Scientific Contributions
- Identified REDD2 as a novel therapeutic target for type 2 diabetes—bridging basic research with translational medicine.
- Works across disciplines such as molecular biology, endocrinology, and nutritional biochemistry.
Project Leadership & Industry Engagement
- Led or participated in 14 major research projects.
- 5 consultancy/industry-based projects, reflecting application-oriented research.
Academic and Collaborative Network
- Strong academic collaborations with Professors Hiroshi Inui and Ryoichi Yamaji.
- Member of prestigious scientific societies (e.g., Japanese Biochemical Society, Japan Society of Nutrition and Food Science).
Scientific Versatility
- Contributions span fundamental mechanisms (e.g., oxidative stress, insulin signaling) to dietary interventions (e.g., mogrol, oleamide).
- Demonstrates ability to bridge molecular insights with systemic physiological outcomes.

⚙️ Areas for Improvement:

International Visibility and Engagement
- Expanding participation in international conferences and editorial boards could elevate his global scientific standing.
- Pursuing cross-border collaborations would further enrich the translational value of his work.
Commercialization and Patent Activity
- While one patent is noted, increased focus on intellectual property development and biomedical commercialization could further validate his applied research strength.
Outreach and Communication
- More active public science communication (e.g., webinars, policy advocacy, media coverage) would amplify the societal impact of his research.

🎓 Education:

Naoki Harada received his Ph.D. in Life Sciences from Osaka Prefecture University, Osaka, Japan, in September 2007. His doctoral studies laid the foundation for his interdisciplinary research in molecular biology, biochemistry, and endocrinology. Harada’s academic path was driven by a keen interest in the cellular and molecular mechanisms underlying metabolic regulation, particularly in relation to glucose homeostasis and pancreatic function. His education provided him with a solid grounding in experimental techniques, critical thinking, and scientific communication, which have become hallmarks of his later work. The institution, known for excellence in biosciences, enabled Harada to cultivate a strong research acumen. His academic training was complemented by exposure to applied research, linking basic science with clinical and nutritional applications—an approach that he has continued to emphasize throughout his career. His strong educational background plays a pivotal role in his current research endeavors and professional development.

💼 Experience:

Dr. Naoki Harada began his academic career in 2008 as an Assistant Professor at the Graduate School of Life and Environmental Sciences, Osaka Prefecture University. He was promoted to Lecturer in 2015, and subsequently to Associate Professor in 2019. Since 2022, he has served as Associate Professor at the Graduate School of Agriculture, Osaka Metropolitan University. Harada has consistently combined teaching with intensive research, mentoring graduate students while advancing his lab’s focus on metabolic diseases and endocrine physiology. His experience includes leading 14 research projects, consulting on 5 industry-linked nutrition initiatives, and co-authoring over 75 scientific papers. His experience reflects a blend of academic leadership, scientific innovation, and multidisciplinary collaboration. Notably, Harada’s role in identifying REDD2 as a therapeutic target exemplifies his contribution to translational science. He maintains strong academic partnerships and actively contributes to several professional societies, making him a respected figure in Japan’s scientific community.

🔬 Research Focus:

Naoki Harada’s research is at the intersection of molecular biology, endocrinology, and nutrition science, with a particular focus on pancreatic β-cell physiology and glucose metabolism. He investigates how oxidative stress, hormonal signals, and metabolic regulators influence insulin secretion and β-cell viability. One of his pivotal contributions is identifying the REDD2 gene as a negative regulator of β-cell function, offering novel therapeutic targets for type 2 diabetes mellitus. His studies also explore nutrient-sensing pathways, G-protein-coupled receptors, and hormonal modulation of energy metabolism. Harada’s recent work delves into the effects of dietary compounds like mogrol and oleamide on metabolic health, linking molecular mechanisms to real-world dietary interventions. His ability to bridge bench science with clinical and nutritional applications sets his research apart. Through collaborations with leading experts and high-impact publications, Harada continues to advance knowledge in the prevention and treatment of metabolic disorders.

📚 Publications Top Notes:

🧬 REDD2 confers pancreatic β-cell dysfunction in high-fat diet-fed mice – Journal of Biological Chemistry, 2025
🦷 Androgens suppress ST3GAL1/4, modulating mucin glycosylation and microbiota in mice – Bioscience, Biotechnology, and Biochemistry, 2025
🍟 CRTC1 in MC4R cells regulates dietary fat intake – FASEB BioAdvances, 2024
💉 Insulin reduces ER stress-induced apoptosis in INS-1 β-cells – Physiological Reports, 2024
🍬 Mogrol activates GPBAR1 and insulin secretion, alleviates hyperglycemia – Scientific Reports, 2024
🔥 Androgen receptor suppresses β-adrenoceptor-mediated thermogenesis – Journal of Biological Chemistry, 2022
🏥 Age-dependent sex differences in NAFLD in TSOD and db/db mice – PLOS ONE, 2022
🐭 Dietary oleamide attenuates obesity in caged mice – Bioscience, Biotechnology, and Biochemistry, 2022
🌿 Curcumin targets GPR55 receptor – npj Science of Food, 2022
💪 Oleamide rescues muscle atrophy in small-caged mice – British Journal of Nutrition, 2021

🧾 Conclusion:

Dr. Naoki Harada demonstrates a clear trajectory of research excellence, grounded in scientific rigor and driven by impactful biomedical questions. His ability to identify molecular mechanisms (e.g., REDD2’s role in β-cell dysfunction) and propose therapeutic directions sets him apart as a leading academic in metabolic disease research. His publication record, industry collaborations, and professional memberships underscore a mature and influential academic career.

Carlos Cruchaga | Neuronal Cell Biology | Best Researcher Award

Published on 21/05/202521/05/2025 by Cell Biologist

Dr. Carlos Cruchaga | Neuronal Cell Biology | Best Researcher Award

Dr. Carlos Cruchaga, Washington Univeristy, United States

Dr. Carlos Cruchaga is a tenured Professor at Washington University School of Medicine, with joint appointments in Psychiatry, Genetics, and Neurology. He is the Director of the NeuroGenomics and Informatics Center and leads multiple high-impact cores including the Knight ADRC, DIAN Genetics Core, and Biorepository Core for initiatives like the Dystonia Coalition and Aging Adult Brain Connectome. Internationally recognized for his pioneering work in neurodegenerative diseases, Dr. Cruchaga specializes in integrating multi-omic datasets to identify novel genetic and molecular mechanisms underlying Alzheimer’s disease and other neurological disorders. He has authored over 340 peer-reviewed publications and continues to lead major NIH-funded projects. With a strong commitment to translational research, he also contributes to tool development for omics data analysis. His work consistently bridges the gap between basic research and clinical application, making him a deserving candidate for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

Leadership: Director of NeuroGenomics and Informatics Center; leads major genetics cores (Knight ADRC, DIAN, Dystonia Coalition, AABC).
Research Impact: Over 346 peer-reviewed publications with significant contributions in Alzheimer’s Disease (AD), neurodegeneration, multi-omics, and genetic epidemiology.
Translational Focus: Discoveries such as rare variants in AD-related genes (APP, PSEN1, PSEN2, PLD3, TREM2) and biomarker identification have major clinical implications.
Global Collaborations: Works with international research consortia including ADNI, GERAD, and Alzheimer’s Research UK, showing both scientific influence and collaboration.
Recognition: Invited speaker at high-level conferences; selected for the prestigious Spanish “Excellence Campus 2005”.
Innovation: Pioneered multi-omic and bioinformatic pipelines for biomarker discovery.

⚠️ Areas for Improvement:

Public Outreach: While academically exceptional, public or patient-facing outreach or science communication isn’t highlighted.
Diversity Initiatives: Potential to expand into mentorship programs or initiatives focused on increasing diversity in genomics.
Commercialization: There is room to emphasize translational science through startups, patents, or technology transfer.

🎓 Education:

Dr. Cruchaga earned his undergraduate degree in Biochemistry from the University of Navarra, Pamplona, Spain (1996–2000). He continued his graduate studies at the same institution, obtaining an MA (2000–2002) followed by a PhD in Biochemistry and Molecular Biology in 2005. His doctoral research, awarded Summa Cum Laude, focused on molecular mechanisms and biomarkers associated with neurodegenerative diseases. Dr. Cruchaga was selected among Spain’s top 18 PhD students to present his research at the “Excellence Campus 2005,” hosted by the Spanish Government and attended by Nobel Laureates. His training included foundational roles as a student and teaching assistant in the Department of Biochemistry and Molecular Biology, setting the stage for a career deeply rooted in research excellence and academic mentorship. This strong academic background has been instrumental in shaping his translational approach to complex neurological conditions like Alzheimer’s and dystonia.

💼 Experience:

Dr. Cruchaga has amassed extensive experience across academic, administrative, and research leadership roles. Since 2019, he has served as a Professor in Psychiatry, Genetics, and Neurology at Washington University. He is also the current Director of the NeuroGenomics and Informatics Center (since 2018), where he supervises multi-disciplinary teams and oversees high-throughput genomics operations. He leads cores in major initiatives such as the Knight Alzheimer’s Disease Research Center (ADRC), DIAN (Dominantly Inherited Alzheimer Network), and the Dystonia Coalition. Earlier roles include serving on the Alzheimer’s Association International Conference Scientific Program Committee (2014–2017), where he curated session topics, evaluated hundreds of abstracts, and chaired sessions. His international collaborations span omics, imaging, and computational biology, making him a leader in neurogenomics. These diverse roles have allowed Dr. Cruchaga to influence both scientific innovation and strategic planning within global neuroscience research initiatives.

🏅 Honors and Awards:

Dr. Cruchaga’s excellence has been recognized through numerous awards and invitations. In 2005, he was chosen for “Excellence Campus 2005,” a prestigious event featuring the top Spanish PhD students alongside Nobel Prize winners. He has received multiple invitations for keynote lectures and seminars at institutions across Europe and the U.S., including the University of the Basque Country, the Center for Applied Medical Research in Pamplona, and Washington University. He was a finalist for the O’Leary Award for Research in Neuroscience in 2009. His service as a Scientific Program Committee Member for the Alzheimer’s Association International Conference further underscores his leadership in the field. These accolades not only celebrate his scientific contributions but also affirm his status as a thought leader in neurodegenerative disease research. His peer-reviewed work has appeared in top-tier journals like Nature, Neuron, and Acta Neuropathologica.

🔬 Research Focus:

Dr. Cruchaga’s research centers on understanding the molecular and genetic underpinnings of neurodegenerative diseases, particularly Alzheimer’s disease, using integrative multi-omics approaches. His lab specializes in analyzing genomic, transcriptomic, proteomic, and metabolomic data from human biospecimens to uncover biomarkers, risk variants, and causal pathways. He has led groundbreaking studies identifying rare coding variants in genes like TREM2, PLD3, and APP, linking them to Alzheimer’s pathology. He applies advanced computational tools and machine learning to interpret high-dimensional data and translate findings into diagnostic and therapeutic strategies. As director of several national consortia cores (e.g., Knight ADRC, DIAN), he facilitates data-sharing and harmonization across global cohorts. His work also explores the genetic architecture of disorders like dystonia and peripheral neuropathy. The long-term goal of his research is to bridge omics data with clinical outcomes to enable personalized medicine in neurology.

📚 Publications Top Notes:

🧠 Rare variants in APP, PSEN1 and PSEN2 increase AD risk in late-onset families – PLoS One (2012)
🧬 GWAS of CSF tau levels reveals novel AD risk variants – Neuron (2013)
🧠 Rare coding variants in PLD3 gene confer AD risk – Nature (2014)
🧠 TREM2 coding variants increase AD risk – Human Molecular Genetics (2014)
🧪 TREM2 variants linked to AD risk in African Americans – Mol Neurodegeneration (2015)
🧫 Higher CSF soluble TREM2 linked to AD mutation status – Acta Neuropathologica (2016)
🧪 Genetics of plasma analytes identifies novel biomarkers – Scientific Reports (2016)
🧬 Variants in Mendelian AD genes within ADSP – JAD (2025)
🧠 RFC1 AAGGG repeat expansions common in neuropathy – Preprint (2025)
🧪 Plasma proteomics uncovers novel AD biomarkers – Preprint (2025)

🧾 Conclusion:

Dr. Carlos Cruchaga exemplifies the highest standards of neuroscience and genomics research. His contributions have advanced the global understanding of Alzheimer’s disease, making him a top-tier candidate for the Best Researcher Award. His scientific leadership, prolific output, and translational success position him as a standout in the biomedical field.

Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Published on 05/05/202505/05/2025 by Cell Biologist

Prof. Dr. Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin, Gazi University Faculty of Dentistry, Turkey

Prof. Dr. Sibel Elif Gültekin is a renowned academic and clinician in Oral Pathology and Periodontology at Gazi University Faculty of Dentistry, Türkiye. With over two decades of experience, she has significantly advanced molecular understanding of odontogenic tumors, HPV-induced oral lesions, and periodontal regeneration. Holding both DDS and Ph.D. degrees, she has led her department as Chair for 10 years and contributed globally as a visiting researcher and advisor. Her collaborations with institutions like the University of Cologne and UCSF reflect her international impact. She has published extensively in high-impact journals, authored books, and mentored numerous young researchers. Her dedication has been recognized through editorial appointments and professional society memberships. Prof. Gültekin’s translational research bridges pathology and clinical dentistry, making her a pioneer in the diagnosis and treatment of oral diseases.

Publication Profile:

Orcid

✅ Strengths for the Award:

Dual Specialization & Academic Leadership: Prof. Gültekin’s rare dual Ph.D. in Oral Pathology and Periodontology, along with her decade-long leadership as department chair, highlights deep academic and organizational expertise.
High Research Output & Impact: With 96 publications, 50+ research projects, and citations exceeding 1300 (Google Scholar), her scholarly productivity and influence are clear. Her h-index across databases (14–17) confirms consistent academic contribution.
Global Collaborations: Active collaborations with international centers like UCSF and University of Cologne underscore her role in global scientific advancement.
Innovative Research Areas: She works at the forefront of molecular oncology, focusing on HPV-associated oral cancers, odontogenic tumors, and biomarkers like P16, VIM3, and PDCD4.
Educational & Editorial Leadership: Served on scientific and editorial boards, symposiums, and advisory panels; she also authored 2 academic books and guided national congresses.
Professional Societies: Active member of multiple esteemed societies (IAOP, ESP, EHNS, IADR), reflecting recognition in the international scientific community.

⚙️ Areas for Improvement:

Clinical Translation Scaling: While her biomarker discoveries are notable, increasing efforts to lead translational clinical trials could accelerate therapeutic application.
Policy Advocacy: Engaging more in international oral health policy or WHO-affiliated programs could amplify her impact beyond academia.
Mentorship on Global Scale: Expanding formal international mentorship programs or fellowships could further cement her influence and legacy.

🎓 Education:

Prof. Dr. Sibel Elif Gültekin holds both DDS and Ph.D. degrees, specializing in Oral Pathology and Periodontology. She completed her undergraduate dental studies at Gazi University Faculty of Dentistry, where she later pursued her doctoral studies. Her academic training extended beyond Türkiye through international fellowships and research placements, including the prestigious Department of Medicine and Stomatology at the University of California San Francisco (UCSF) and the Institute for Pathology at the University of Cologne. Her educational journey is marked by an interdisciplinary approach, blending basic sciences and clinical applications. These robust academic foundations have positioned her as a global expert in oral cancer biomarkers, regenerative periodontology, and molecular pathology, nurturing future dentists and researchers through an integrative, evidence-based curriculum and global research exposure.

💼 Experience:

Prof. Dr. Gültekin has over 25 years of experience in dentistry, oral pathology, and periodontology. She has served as Professor and Chair of the Department of Oral Pathology at Gazi University, shaping both academic curricula and national diagnostic standards. Internationally, she collaborated with UCSF and the University of Cologne on pioneering projects in oral cancer and HPV research. Her clinical and academic background spans over 50 funded research projects, with 96 published papers in prestigious journals indexed by SCI, Scopus, and PubMed. She has contributed to oral health policy through editorial and advisory roles, including at journals like Journal of Oral Health Frontiers. Her expertise has guided scientific boards and symposia in Türkiye and beyond, particularly in head and neck pathology. She remains a sought-after consultant and reviewer, advocating for personalized medicine and molecular diagnostics in oral health.

🔬 Research Focus:

Prof. Dr. Sibel Elif Gültekin’s research centers on the molecular mechanisms of oral diseases, particularly odontogenic tumors, oral epithelial dysplasia, and HPV-induced carcinomas. She has made key contributions in identifying biomarkers such as P16, PDCD4, VIM3, and CD8+ T-cell infiltrates, enhancing early diagnosis and prognosis of oral and oropharyngeal cancers. Her research also explores microsatellite instability and loss of heterozygosity in oral squamous cell carcinoma. Additionally, she has contributed to periodontal tissue regeneration studies and the development of personalized therapeutic strategies. With over 1,300 citations and an h-index of 17 on Google Scholar, her impactful work bridges molecular science and clinical application. Collaborating with global experts in pathology, oncology, and molecular biology, Prof. Gültekin’s research not only contributes to academic literature but also informs clinical protocols and treatment pathways in modern dentistry and oral oncology.

📚 Publications Top Notes:

🧬 Microsatellite Instability and Loss of Heterozygosity as Prognostic Markers in Oral Squamous Cell Carcinoma (Genes, Chromosomes and Cancer, 2024)
🧪 Efficiency of B-RAF-/MEK-inhibitors in B-RAF Mutated Ameloblastoma: Case Report and Review (Heliyon, 2023)
🦷 Kişiselleştirilmiş Diş Hekimliği (ADO Klinik Bilimler Dergisi, 2023)
🔍 Apoptosis Related PDCD4: Promising Novel Biomarker for Early Detection of Oral Cancer (ADO Klinik Bilimler Dergisi, 2022)
🛡️ PD-L1 Expression and High CD8+ Lymphocyte Infiltrate Predict Outcome in Oropharyngeal SCC (International Journal of Molecular Sciences, 2020)

🧾 Conclusion:

Prof. Dr. Sibel Elif Gültekin is a highly deserving nominee for the Best Researcher Award. Her pioneering contributions in oral pathology, particularly in molecular diagnostics and HPV-related oral oncology, place her at the forefront of dental research. Her exceptional academic record, leadership, and dedication to collaborative and translational science make her a standout candidate who embodies the spirit of innovation, mentorship, and global impact.